1] Braman Family Breast Cancer Institute, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA [2] Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL, USA.
1] Braman Family Breast Cancer Institute, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA [2] Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL, USA [3] Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Oncogene. 2014 May 1;33(18):2341-53. doi: 10.1038/onc.2013.197. Epub 2013 Jun 17.
Estrogen triggers transactivation coupled estrogen receptor α (ERα) proteolysis, but mechanisms thereof remain obscure. Present data link estrogen:ERα-driven transcription with cell cycle progression. Although liganded ERα induces many genes within 1-4 h, gene activation after 6 h is thought to be indirect. Here, we identify SKP2 as a late-acting coactivator that drives ERα targets to promote G1-to-S progression. Data support a model in which estrogen-activated cyclin E-CDK2 binds and phosphorylates ERαS341, to prime ERα-SCF(SKP2) binding via SKP2-L248QTLL252 in late G1. SKP2 activates ERα ubiquitylation and proteolysis. Putative late ERα targets were identified by expression profiling. SKP2 knockdown attenuated E2F-1 and BLM induction. SKP2 overexpression, but not coactivator motif mutant SKP2-L248QTAA252, enhanced estrogen-induced E2F-1 and BLM expression. SKP2 knockdown impaired estrogen-stimulated ERα, SKP2, SRC3 and RNA polymerase II recruitment to E2F-1 and BLM promoters. This work not only identifies these late-activated genes as bona fide ERα targets but describes a novel mechanism for their periodic activation. SKP2 serves as dual ERα E3 ligase/coactivator for late-activated target genes, revealing a novel mechanism whereby ERα/SCF(SKP2) transactivation of E2F-1 feeds forward to drive G1-to-S.
雌激素触发与雌激素受体 α(ERα)蛋白水解偶联的转激活,但其中的机制尚不清楚。目前的数据将雌激素:ERα 驱动的转录与细胞周期进展联系起来。尽管配体 ERα 在 1-4 小时内诱导许多基因,但认为 6 小时后的基因激活是间接的。在这里,我们将 SKP2 鉴定为一种晚期作用的共激活因子,它可以驱动 ERα 靶基因促进 G1 期到 S 期的进展。数据支持这样一种模型,即雌激素激活的细胞周期蛋白 E-CDK2 结合并磷酸化 ERαS341,通过 SKP2-L248QTLL252 在晚期 G1 中为 ERα-SCF(SKP2)结合做好准备。SKP2 激活 ERα 泛素化和蛋白水解。通过表达谱鉴定了推定的晚期 ERα 靶标。SKP2 敲低减弱了 E2F-1 和 BLM 的诱导。SKP2 过表达,而不是共激活因子模体突变体 SKP2-L248QTAA252,增强了雌激素诱导的 E2F-1 和 BLM 表达。SKP2 敲低损害了雌激素刺激的 ERα、SKP2、SRC3 和 RNA 聚合酶 II 募集到 E2F-1 和 BLM 启动子。这项工作不仅将这些晚期激活的基因鉴定为真正的 ERα 靶标,而且还描述了它们周期性激活的新机制。SKP2 是 ERα 的双重 E3 连接酶/共激活因子,用于晚期激活的靶基因,揭示了一种新的机制,即 ERα/SCF(SKP2)对 E2F-1 的转激活反馈驱动 G1 期到 S 期。